Warnings
Warnings (Warnings)
Neuroquell-plus
FDA Label NDC 66233-714
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Atlantic Management Resources Inc for the product Neuroquell-plus (NDC 66233-714). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, warnings, inactive ingredient, otc - keep out of reach of children, otc - purpose, dosage & administration section, indications & usage section, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Dosage & Administration Section
When you are ready to apply Neuroquell, remove the cap, turn the bottle upside down, and gently roll the applicator onto the area of discomfort in a continuous, back-and-forth motion to cover approximately one-half of the area of your pain. If using either the sample swab or towelette, apply in a similar way. Your skin will remain moist for a few minutes. Close cap tightly after use, and wash hands thoroughly. Feel free to reapply 4-to-6 hours later and up to 3 additional times per day. To eliminate the peppermint scent, you can wash the treated area with soap and water 15 minutes after the application. This will not affect the efficacy of the product. If there is highlights text then the SPL document title should include the following text string without quotation marks: These highlights do not include all the information needed to use see full prescribing information for and Initial U.S. Approval
Indications & Usage Section
Temporarily relieves pain associated with minor aches and pains of muscles, joints, nerve-based pain and headaches/migraines. Individual results may vary.
* Please review the disclaimer below.
